Greene is a residency and fellowship-trained orthopedic surgeon who has shifted completely into business. He started a healthcare internet marketing company, US Lead Network, that helps medical and dental practices acquire patients on the web in a pay-for-performance manner. The company is now using Artificial Intelligence for marketing which is lowering the cost per lead substantially. He has written two books on Healthcare Internet Marketing that are available for purchase on Amazon. He has been featured as a Top 20 Expert Author by Ezines.com, the top article directory site in the world. Out of over 470,000 authors, Greene ranks #15 as an Expert Author and #1 in the Pain Management category. He also started a regenerative medicine company, R3 Stem Cell, that offers marketing, an IRB-approved protocol, and top products for practices nationwide. R3 offers stem cell training courses that are second to none at https://stemcelltrainingcourse.org

Annunziata Mauro is an Associate Professor at the University of Teramo. She is the coordinator of the Bachelor's degree in Biotechnology. Her research interests mainly focus on studying stem cells of amniotic origin and their application in regenerative medicine and tissue engineering in species of veterinary interest with translational potential in humans. She translates her intellectual and technical knowledge developed in the fields of Cell Biology and Reproductive Biology into the study of amniotic stem cells and their therapeutic potential role, applying the latest and most innovative research techniques and operating within national and international research networks. She participates at National (PRIN, FFABR, PNRR) and European (H2020-EU.1.3.1.-MSCA-ITN 2015-EJD: REP-BIOTECH; H2020-EU.1.3.4.- MSCA-COFUND-2015-DP: REP-EAT; H2020-MSCA-ITN-2020-MSCA-ITN EJD: P4FIT) research projects. She has built her university commitment after years of experience in research, evaluation, teaching, and administration in academic institutions. 

Barbara Barboni is a cell biologist from years addressed the study of reproductive-derived cells’ function. Her scientific expertise has always made use of both theoretical (systems biology) and experimental approaches in vitro and in vivo mainly on preclinical models of regeneration. She has built her university commitment after years of experience in research, evaluation, teaching, and administration in university and ministerial institutions.

Valentina Russo is a Full Professor of Anatomy at the University of Teramo. Valentina is the coordinator of the PhD program in Cellular and Molecular Biotechnology. Her research interests mainly focus on amniotic epithelial stem cells and their application in regenerative medicine and tissue engineering, particularly for tendon therapy. She is the Principal Investigator of national (PRIN, FIRB, PNRR) and European (H2020-MSCA) research projects, particularly leading the H2020-MSCA-ITN EJD-2020-P4 FIT project (Perspectives For Future Innovation in Tendon repair). She has built her university commitment after years of experience in research, evaluation, teaching, and administration in academic institutions.

Dr. Alon Yaar: Founder and former CEO at NeuroDerm (CNS pharma company), a unikorn bought by Mitsubishi Tanabe Pharma in 2017 for more than 1B$. Alon is a healthcare professional executive and serial entrepreneur with more than 25 years in the pharma and biotech industry. Dr. Yaar is an expert in developing novel therapies to make key, transformational, and effective changes in patient’s lives. Alon is working now on his next medical breakthrough startup - LiveKidney, which promises to delay the need for kidney transplantation or dialysis, using UC-MSCs technology.

Prof Dr Frank J.T. Staal obtained his bachelor's and master's degrees (both cum laude) in Medical Biology at Utrecht University. He obtained his PhD degree (1993) at the Department of Genetics, Stanford University School of Medicine under the supportive guidance of professors Leonard and Leonore Herzenberg where was taught the intricacies of flow cytometry. His thesis dealt with transcriptional regulation of HIV expression in T-lymphocytes and involved many functional flow cytometric assays and cell sorting experiments. In 1993 he became a postdoctoral fellow at the Netherlands Cancer Institute for 2 years, after which he moved back to Utrecht University as a fellow of the Royal Academy of Sciences (KNAW) in the laboratory of Professor Hans Clevers. In 2000 he was recruited to Erasmus Medical Center (EMC) Rotterdam to start his laboratory on human T cell development and became an assistant professor. In 2004 he was appointed associate professor at EMC and expanded his research to Wnt signaling in blood stem cells and T cells, as well as to gene therapy for immune disorders. In 2008 he was recruited to the Leiden University Medical Center (LUMC) and became a full professor of Molecular Stem Cell biology. His research focuses on stem cell biology and lymphocyte development, including thymus biology. He has brought stem cell-based gene therapy for several types of SCID to the clinic, in an expanding portfolio that includes immune deficiencies and lysosomal storage diseases. Staal coordinates several large European and national consortia in the area of clinical gene therapy.

De la Parra-Solomon is an entrepreneur focused on Information Technology, Education, and Health. He is creative, results-driven, and has 16+ years of Digital Strategy experience in architecture and implementation. De la Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions. He serves as COO and Co-founding Partner at The Solomon Brokerage Firm. He also leads as Vice President of Digital Strategy at Mass Media Division, while being the CEO of De la Parra Mobile Solutions. He is the former Vice President of Strategy and Operations at PetroM Corp and its subdivisions PetroM Logistics and PetroM Pharma, and the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra-Solomon is the former CEO & Founder of Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is a former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, De la Parra-Solomon acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a former member of the WAMS Executive Council (WAMS Executive Board), a former member of the WAMS Education & Training Board (ETB), a former member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & was also a Senior Partner at WAMS, The World Academy of Medical Sciences. He was also an Advisory Board member, functioned as the Chief Operating Officer, and was a Co-founding Partner at The Reprogramming Medicine Association. De la Parra-Solomon is also a member of Singularity University and OpenExo. About the organizations that Mr. De la Parra has collaborated with for social impact and empowerment, he is a member of the Laurentia Project and of Cerebro Mexico, he serves as an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center – Cyprus Neuroscience & Technology Institute (Senior TV Program), while also being a Federated Member of the International Longevity Alliance and a member of the Transhumanist Party. He is a voting citizen and is running for Mayor & future Parliamentary Candidate at Asgardia. He served as the Chief Digital Strategy Officer and is a Member of the Board of Advisors and an Honorary Member at the Transdisciplinary Agora for Future Discussions, a member of the Web Committee at the Life Extension Advocacy Foundation/Lifespan.io, volunteered with the SENS Research Foundation for the OncoSENS Program in Digital Strategy, and acted as Digital Strategy adviser at the Major Mouse Testing Program. He also functioned as the founder and former Board of Directors member of Astrum Fundación and was a Digital Strategy Advisor for POKI Ciudad Orgánica. He is also a part of the General Member Board at the National Autism Association, the National Fibromyalgia Association, the International Literacy Association, and the United Spinal Association. De la Parra-Solomon is also a member of several associations for technology including the World Blockchain Association, the EU Blockchain Observatory & Forum, the Blockchain Industry Group, the Computing Technology Industry Association, the Internet Marketing Association, the Application Developers Alliance, and the Association of Strategic Marketing. For the energy sector, he worked as the Vice President of Strategy & Operations of PetroM Energy and is a member of the National Introducing Brokers Association and a part of the National Biodiesel Board (Alliance Program). De la Parra-Solomon’s activities in arts & culture involve being a member of Sociedad de Autores y Compositores de México, while also being a member of the Executive Board at Sociedad Latinoamericana de Ópera. He also served as a Digital Strategy Advisor at the Xicome Festival. He is a media professional at IMDB, SoundCloud, and ReverbNation and has had activities in the entertainment industry as a music producer, composer & arranger for Televisa with broadcast television, film, radio, and web, receiving international awards with aired content in more than 185 countries.

Susanna Uusmaa is a biomedical scientist with broad expertise in Medical Sciences and International Business. Holding an MSBS degree, she is result-driven to integrate modern smart technologies into making substantive contributions to the biomedical sector. Having conducted research in neuroscience and oncology and having proudly graduated from Tallinn University of Technology (TALTECH) and Tallinn University School of Natural Sciences and Health, Uusmaa takes an evidence-based approach to her professional objectives and also to her endeavors as a passionate healthy lifestyle entrepreneur. With a background in biomolecular and medical sciences, she has recently co-founded Quantum Brain Research Institute to support the development of neuroscientific research for neurocritical treatment applications through instructive programs in mental health assessment and management. In collaboration with the Luxembourg Institute of Health and Luxembourg Centre for Systems Biomedicine, she developed a complete standard operating procedure for differentiating and generating fully functional glial cells from induced pluripotent stem cells (iPSCs) in only 30 days. Moreover, she holds over 6 years of hard-working experience in business operations and relationship building in more than 5 countries around the globe, having created and nurtured mutually beneficial partnerships, enhanced workflow efficiency, and contributed to the growth of several initiatives with substantial savings. Ms. Uusmaa’s biomedical undertakings have positioned her as an MSBS able to become an active contributor also to the longevity sector and put her expertise into helping people become their best version of themselves with properly validated and ethical practices. She considers herself lucky to be born in the beautiful Northern European city of Tallinn in Estonia, a UNESCO World Heritage treasure of the Baltic Sea, where women’s rights are valued and where cutting-edge technologies are implemented in e-governance and healthcare. Uusmaa brings strong organizational and unique interpersonal abilities to her scope of action with the ultimate goal of integrating smart and efficient solutions to the biomedical sector and creating awareness of healthy living & healthy aging.